![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, September 06, 2018 5:17:42 PM
Posted on August 29, 2018
Comments
"Canbiola Inc (OTCMKTS:CANB) might as well have run ahead of fundamentals on rallying by more than 300% after remaining under pressure for the better part of the first half of the year. The explosive rise has seen the stock establish itself as a volume leader in the market."
What Does Canbiola Do?
"Canbiola is a cannabis-focused company specializing in the sale of CBD based products such as oils, creams, and moisturizers. The company is currently developing a line of proprietary products in addition to seeking synthetic growth through acquisitions in the industry."
Why did Canbiola Explode?
"The catalyst behind the recent price surge is a presser whereby the Chief Executive Officer Marco Alfonsi, reiterated that they had made important strides in penetrating new markets. According to the chief executive officer, they remain focused on engaging strategic medical partners as part of the latest push to grow exposure exponentially.
In addition, Canbiola doubled its revenues in the second quarter at the back of an aggressive marketing campaign backed by a robust product line."
"Buoyed by the second quarter sales numbers, the company has embarked on a nationwide rollout campaign as it looks to target a broader target market. The company expects exponential sales growth to doctors and medical facilities going forward."
"Over the next 12 months, Canbiola is to focus on expanding the size of third manufacturing facilities, manufacturing its products. The company intends to expand the size, in a bid to keep up with growing demand for its cannabis products according to the Chief executive officer."
“The results speak for themselves. The product is being accepted. The doctors are now starting to refer more physicians to us. So, when you have physicians referring other physicians, we’re obviously on the right path,” said Mr. Alfonsi.
According to the Chief executive Officer, Canbiola is looking forward to being one of the beneficiaries of the exciting times in the industry. For starters, physicians are becoming increasingly aware of alternatives to drugs, especially cannabis drugs, found to be viable alternatives for addressing various medical conditions while reducing the risk of addiction.
“Our nationwide Roll-Out has begun and continues to grow dramatically due to our strong affiliation with very clear-cut distribution channels. We see exponential growth to Doctors and Medical Practices nationwide selling Canbiola products. We have developed a new section on our site to help our potential clients locate doctors and practices in their locality,” Canbiola in a statement.""
Recent CANB News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:58:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 05:29:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 09:08:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:54:44 PM
- Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million • InvestorsHub NewsWire • 03/11/2024 12:34:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:02:41 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:38:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:52:26 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/08/2024 06:08:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 12:52:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 03:36:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 10:15:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:18:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 02:44:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 06:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 08:57:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:12:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:41:28 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM